Patents by Inventor Kevin V. Martin
Kevin V. Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20170088865Abstract: The present invention provides methods for producing a product of one or more enzymatic pathways. The pathways used in the methods of the invention involve one or more conversion steps such as, for example, an enzymatic conversion of guluronic acid into D-glucarate (Step 7); an enzymatic conversion of 5-ketogluconate (5-KGA) into L-Iduronic acid (Step 15); an enzymatic conversion of L-Iduronic acid into Idaric acid Step 7b); and an enzymatic conversion of 5-ketocluconate into 4,6-dihydroxy 2,5-diketo hexanoate (2,5-DDH) (Step 16). In some embodiments the methods of the invention produce 2,5-furandicarboxylic acid (FDCA) as a product. The methods include both enzymatic and chemical conversions as steps. Various pathways are also provided for converting glucose into 5-dehdyro-4-deoxy-glucarate (DDG), and for converting glucose into 2,5-furandicarboxylic acid (FDCA).Type: ApplicationFiled: December 13, 2016Publication date: March 30, 2017Inventors: Spiros Kambourakis, Benjamin M. Griffin, Kevin V. Martin
-
Patent number: 9528133Abstract: The present invention provides methods for producing a product of one or more enzymatic pathways. The pathways used in the methods of the invention involve one or more conversion steps such as, for example, an enzymatic conversion of guluronic acid into D-glucarate (Step 7); an enzymatic conversion of 5-ketogluconate (5-KGA) into L-Iduronic acid (Step 15); an enzymatic conversion of L-Iduronic acid into Idaric acid Step 7b); and an enzymatic conversion of 5-ketocluconate into 4,6-dihydroxy 2,5-diketo hexanoate (2,5-DDH) (Step 16). In some embodiments the methods of the invention produce 2,5-furandicarboxylic acid (FDCA) as a product. The methods include both enzymatic and chemical conversions as steps. Various pathways are also provided for converting glucose into 5-dehdyro-4-deoxy-glucarate (DDG), and for converting glucose into 2,5-furandicarboxylic acid (FDCA). The methods also involve the use of engineered enzymes that perform reactions with high specificity and efficiency.Type: GrantFiled: March 21, 2014Date of Patent: December 27, 2016Assignee: Synthetic Genomics, Inc.Inventors: Spiros Kambourakis, Benjamin M. Griffin, Kevin V. Martin
-
Patent number: 9506090Abstract: The present invention provides methods for producing a product of one or more enzymatic pathways. The pathways used in the methods of the invention involve one or more conversion steps such as, for example, an enzymatic conversion of guluronic acid into D-glucarate (Step 7); an enzymatic conversion of 5-ketogluconate (5-KGA) into L-Iduronic acid (Step 15); an enzymatic conversion of L-Iduronic acid into Idaric acid Step 7b); and an enzymatic conversion of 5-ketocluconate into 4,6-dihydroxy 2,5-diketo hexanoate (2,5-DDH) (Step 16). In some embodiments the methods of the invention produce 2,5-furandicarboxylic acid (FDCA) as a product. The methods include both enzymatic and chemical conversions as steps. Various pathways are also provided for converting glucose into 5-dehdyro-4-deoxy-glucarate (DDG), and for converting glucose into 2,5-furandicarboxylic acid (FDCA). The methods also involve the use of engineered enzymes that perform reactions with high specificity and efficiency.Type: GrantFiled: September 20, 2013Date of Patent: November 29, 2016Assignee: Synthetic Genomics, Inc.Inventors: Spiros Kambourakis, Benjamin M. Griffin, Kevin V. Martin
-
Patent number: 9080188Abstract: This invention describes genes, metabolic pathways, microbial strains and methods to produce methylbutanol and other compounds of interest from renewable feedstocks.Type: GrantFiled: November 28, 2011Date of Patent: July 14, 2015Assignee: Synthetic Genomics, Inc.Inventors: Stephen Picataggio, Robert C. Brown, Jessica R. Kristof, Gena Roy, Prachee Prakash, Stuart A. Underwood, Kevin Watts, Kevin V. Martin
-
Publication number: 20140322780Abstract: This invention describes genes, metabolic pathways, microbial strains and methods to produce methylbutanol and other compounds of interest from renewable feedstocks.Type: ApplicationFiled: November 28, 2011Publication date: October 30, 2014Inventors: Stephen Picataggio, Robert C. Brown, Jessica R. Kristof, Gena Roy, Prachee Prakash, Stuart A. Underwood, Kevin Watts, Kevin V. Martin
-
Publication number: 20140206047Abstract: The present invention provides methods for producing a product of one or more enzymatic pathways. The pathways used in the methods of the invention involve one or more conversion steps such as, for example, an enzymatic conversion of guluronic acid into D-glucarate (Step 7); an enzymatic conversion of 5-ketogluconate (5-KGA) into L-Iduronic acid (Step 15); an enzymatic conversion of L-Iduronic acid into Idaric acid Step 7b); and an enzymatic conversion of 5-ketocluconate into 4,6-dihydroxy 2,5-diketo hexanoate (2,5-DDH) (Step 16). In some embodiments the methods of the invention produce 2,5-furandicarboxylic acid (FDCA) as a product. The methods include both enzymatic and chemical conversions as steps. Various pathways are also provided for converting glucose into 5-dehdyro-4-deoxy-glucarate (DDG), and for converting glucose into 2,5-furandicarboxylic acid (FDCA). The methods also involve the use of engineered enzymes that perform reactions with high specificity and efficiency.Type: ApplicationFiled: March 21, 2014Publication date: July 24, 2014Applicant: Synthetic Genomics, Inc.Inventors: Spiros Kambourakis, Benjamin M. Griffin, Kevin V. Martin
-
Publication number: 20140106414Abstract: The present invention provides methods for producing a product of one or more enzymatic pathways. The pathways used in the methods of the invention involve one or more conversion steps such as, for example, an enzymatic conversion of guluronic acid into D-glucarate (Step 7); an enzymatic conversion of 5-ketogluconate (5-KGA) into L-Iduronic acid (Step 15); an enzymatic conversion of L-Iduronic acid into Idaric acid Step 7b); and an enzymatic conversion of 5-ketocluconate into 4,6-dihydroxy 2,5-diketo hexanoate (2,5-DDH) (Step 16). In some embodiments the methods of the invention produce 2,5-furandicarboxylic acid (FDCA) as a product. The methods include both enzymatic and chemical conversions as steps. Various pathways are also provided for converting glucose into 5-dehdyro-4-deoxy-glucarate (DDG), and for converting glucose into 2,5-furandicarboxylic acid (FDCA). The methods also involve the use of engineered enzymes that perform reactions with high specificity and efficiency.Type: ApplicationFiled: September 20, 2013Publication date: April 17, 2014Applicant: SYNTHETIC GENOMICS, INC.Inventors: Spiros KAMBOURAKIS, Kevin V. MARTIN
-
Patent number: 8309323Abstract: This invention describes genes, metabolic pathways, microbial strains and methods to produce 2,6-dimethyloctane as an advanced biofuel from renewable feedstocks.Type: GrantFiled: November 13, 2008Date of Patent: November 13, 2012Assignee: Synthetic Genomics, Inc.Inventors: Kevin V. Martin, Stephen Picataggio, Paul Roessler, John Verruto, Kevin Watts
-
Patent number: 8114641Abstract: This invention describes genes, metabolic pathways, microbial strains and methods to produce methyl butanol and other compounds of interest from renewable feedstocks.Type: GrantFiled: December 10, 2008Date of Patent: February 14, 2012Assignee: Synthetic Genomics, Inc.Inventors: Stephen Picataggio, Robert C. Brown, Jessica R. Kristof, Gena Roy, Prachee Prakash, Stuart A. Underwood, Kevin Watts, Kevin V. Martin
-
Publication number: 20110160501Abstract: This invention describes genes, metabolic pathways, microbial strains and methods to produce 2,6-dimethyloctane as an advanced biofuel from renewable feedstocks.Type: ApplicationFiled: November 13, 2008Publication date: June 30, 2011Inventors: Kevin V. Martin, Stephen Picataggio, Paul Roessler, John Verruto, Kevin Watts
-
Patent number: 7582758Abstract: Methods for the synthesis of cyclic phosphonic acid diesters from 1,3-diols are described, whereby cyclic phosphonic acid diesters are produced by reacting a chiral 1,3-diol and an activated phosphonic acid in the presence of a Lewis acid.Type: GrantFiled: June 3, 2005Date of Patent: September 1, 2009Assignee: Metabasis Therapeutics, Inc.Inventor: Kevin V. Martin
-
Patent number: 6107523Abstract: Novel modified and improved beta-diketones and their use in the extraction of copper from aqueous ammoniacal solutions containing copper values, resulting from commercial processes, including, but not limited to, leaching of copper containing ores, such as sulfidic ores, or concentrates resulting from flotation of such sulfidic ores. The novel diketones are those highly sterically hindered, which may be represented by the formula I or II: ##STR1## The preferred beta-diketones of Formula [II] are selected from the group consisting of neo-alkyl beta-diketones, such as, 1-phenyl-3-neoalkyl-1,3 propanedione in which the neoalkyl group is selected from neohexyl, neoheptyl, neooctyl, neononyl, or neodecyl.Type: GrantFiled: December 17, 1997Date of Patent: August 22, 2000Assignee: Henkel CorporationInventors: Michael J. Virnig, Gary A. Kordosky, Sang I. Kang, Kevin V. Martin, Phillip L. Mattison
-
Patent number: 5936129Abstract: A process for making a sterically-hindered beta-diketone involving: (a) providing a solution comprising: (i) an ester; (ii) a base; and (iii) a solvent; (b) adding a ketone selected from the group consisting of an aromatic ketone and a hindered aliphatic ketone, to the solution, to form a condensation reaction mixture, whereby either the ester or the ketone is hindered; (c) reacting the solution with the ketone to form a sterically-hindered beta-diketone; and (d) recovering the sterically-hindered beta-diketone from the condensation reaction mixture.Type: GrantFiled: January 22, 1998Date of Patent: August 10, 1999Assignee: Henkel CorporationInventors: Kevin V. Martin, Phillip L. Mattison, Michael J. Virnig